Human butyrylcholinesterase (Altimmune)
人丁酰胆碱酯酶
Report date: 2023/02/12 00:15:37
Base Information
Drug NameHuman butyrylcholinesterase (Altimmune)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAltimmune Inc
China Registration ClassN/A